Formoterol - redOrbit

COPD Tops Asthma as the Focus Indication for Next Generation Respiratory Therapies at the 2012 American Thoracic Society Conference

2012-05-31 02:26:36

NEW YORK, May 31, 2012 /PRNewswire/ -- Citeline, the world's leading research authority on pharmaceutical clinical trials, updates, and intelligence recently reviewed the results presented

/C O R R E C T I O N -- Pearl Therapeutics/

2012-05-14 06:27:07

In the news release, Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD, issued 14-May-2012 by Pearl Therapeutics

Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD

2012-05-14 02:27:37

REDWOOD CITY, Calif., May 14, 2011 /PRNewswire/ -- Pearl Therapeutics Inc.

Pearl Therapeutics Creates Nanogram-Dose Inhalers and Initiates a Phase 2b Study to Characterize Ultra-low Doses of Glycopyrrolate

2012-04-03 02:27:09

REDWOOD CITY, Calif., April 3, 2012 /PRNewswire/ -- Pearl Therapeutics Inc.

Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003

2012-01-06 07:47:00

REDWOOD CITY, Calif., Jan. 6, 2012 /PRNewswire/ -- Pearl Therapeutics Inc.

News - Formoterol

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health